Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease
Abstract Midnolin (MIDN) was first discovered in embryonic stem cells, but its physiological and pathological roles are, to date, poorly understood. In the present study, we therefore examined the role of MIDN in detail. We found that in PC12 cells, a model of neuronal cells, MIDN localized primaril...
Saved in:
Main Authors: | Yutaro Obara, Toru Imai, Hidenori Sato, Yuji Takeda, Takeo Kato, Kuniaki Ishii |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/b0a473ce608c4da7bb4b61ac2a2f43c5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson’s disease-like pathology
by: Changhe Wang, et al.
Published: (2018) -
Cognitive alterations in juvenile Parkinson´s disease caused by the C212Y mutation in the Parkin gene.
by: Sonia Moreno, et al.
Published: (2010) -
Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
by: Sangwoo Ham, et al.
Published: (2017) -
Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
by: Thi A Tran, et al.
Published: (2011) -
Deconstructing the molecular genetics behind the PINK1/Parkin axis in Parkinson’s disease using Drosophila melanogaster as a model organism
by: Suchita Ganesan, et al.
Published: (2021)